PCRX FY 2010 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena

PCRXPacira BioSciences, Inc.

$976M

FY 2010 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$15M-3.0% YoY

Gross Profit

$2M15.7% margin

Operating Income

-$22M-153.6% margin

Net Income

-$27M-186.4% margin

EPS (Diluted)

$-1.58

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$32M

Stock-Based Comp.

$23,000

Balance Sheet

Total Assets

$67M

Total Liabilities

$115M

Stockholders' Equity

-$48M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$15M	-3.0%
Gross Profit	$2M	$3M	-15.5%
Operating Income	-$22M	-$29M	+21.6%
Net Income	-$27M	-$32M	+14.4%